The first storefront dispensary in Manhattan has a goal in mind: mainstreaming marijuana. This post from The Fader turns the spotlight on MedMen, the future of buying weed in New York. There are three medical marijuana dispensaries in Manhattan, but only one is designed with the airy minimalism of an Apple store. The others look and feel like doctors offices, but here, at ... Continue Reading
marijuana policy
Impact of Marijuana Policy on People to Be Studied?
A bill, that requires a federal study on the impact of marijuana legalization, has been introduced with the hope that it will combat the outdated information supporting current marijuana policy. This post from High Times discusses the bill. Rep. Tulsi Gabbard (D-HI) introduced legislation on Tuesday that would require a federal study on the impact of marijuana legalization ... Continue Reading
Has This NY Report Paved the Way to Legal Cannabis?
In a recent 75-page assessment report, the New York State Health officials have shown the way to legal cannabis. This post from Leafly highlights the surprising conclusions. One of the nation’s most powerful, prosperous, and populous states is laying the groundwork to end cannabis prohibition. On Friday, July 13, New York State Health Commissioner Howard Zucker released a ... Continue Reading
This FDA Approval Can Revamp Federal Cannabis Policy
The FDA approval of a CBD prescription drug just opened the door to transforming the marijuana policy. This article from The Washington Post, written by John Hudak, discusses how this approval can start a new policy conversation. The Food and Drug Administration did something entirely routine and completely unprecedented Monday: It approved a drug called Epidiolex. What makes ... Continue Reading
Corporate Cannabis: Why Rise in CBD Patents Matters
Companies scramble for CBD patents, igniting fear of corporate cannabis. This post from Cannabis Now highlights how concerns are being raised about the creeping privatization of cannabinoids. Something of a corporate scramble is underway to secure patents for the various curative properties of CBD, and the associated products and procedures. Pharmaceutical firms anticipate a ... Continue Reading